Top

Published in:

01-11-2017 | Letter to the Editor

Is there a link among thrombophilia factors and preeclampsia?

Authors: Danyelle R. A. Rios, Patrícia Nessrala Alpoim, Lara Carvalho Godoi, Fernanda Santos Mendes, Bashir Lwaleed, Lirlândia P. Sousa, Luiza O. Perucci, Maria G. Carvalho, Karina B. G. Borges, Luci M. S. Dusse

Published in: Journal of Thrombosis and Thrombolysis | Issue 4/2017

Excerpt

Dear Editor, …

American College of Obstetricians and Gynecologists (ACOG). Hypertension in pregnancy (2013) Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol 122:1122–1131. doi:10.1097/01.AOG.0000437382.03963.88 CrossRef

Henderson JT, Whitlock EP, O’Connor E et al (2014) Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 160(10):695–703. doi:10.7326/M13-2844 CrossRefPubMed

Alpoim PN, Gomes KB, Godoi LC et al (2011) ADAMTS13, FVIII, von Willebrand factor, ABO blood group assessment in preeclampsia. Clin Chim Acta 412:2162–2166. doi:10.1016/j.cca.2011.07.030 CrossRefPubMed

Dusse LM, Alpoim PN, Lwaleed BA et al (2013) Is there a link between endothelial dysfunction, coagulation activation and nitric oxide synthesis in preeclampsia? Clin Chim Acta 415:226–229. doi:10.1016/j.cca.2012.10.006 CrossRefPubMed

Dusse LM, Godoi LC, Gomes KB et al (2016) Tissue factor-dependent pathway in severe preeclampsia revisited. Blood Coagul Fibrinolysis 27:436–440. doi:10.1097/MBC.0000000000000507 CrossRefPubMed

Cadroy Y, Grandjean H, Pichon J et al (1993) Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre-eclampsia. Br J Obs Gynaecol 100:416–420CrossRef

Caron C, Goudemand J, Marey A et al (1991) Are haemostatic and fibrinolytic parameters predictors of preeclampsia in pregnancy-associated hypertension? Thromb Haemost 66:410–414PubMed

Dekker GA, Sibai BM (1991) Early detection of preeclampsia. Am J Obstet Gynecol 165:160–172. doi:10.1016/0002-9378(91)90245-M CrossRefPubMed

Bertina RM (1997) Factor V Leiden and other coagulation factor mutations affecting thrombotic risk. Clin Chem 43:1678–1683PubMed

10.

Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:3698–3703PubMed

11.

D’Angelo A, Selhub J (1997) Homocysteine and Thrombotic Disease. J Am Soc Hematol 90:1–12

12.

De Maat MPM, De Groot CJM (2011) Thrombophilia and pre-eclampsia. Semin Thromb Hemost 37:106–110. doi:10.1055/s-0030-1270335 CrossRefPubMed

13.

De Groot CJM, Bloemenkamp KWM, Duvekot EJ et al (1999) Preeclampsia and genetic risk factors for thrombosis: a case-control study. Am J Obstet Gynecol 181:975–980. doi:10.1016/S0002-9378(99)70335-2 CrossRefPubMed

14.

Dusse LMS, Carvalho M, das G, Bragança WF et al (2007) Inherited thrombophilias and pre-eclampsia in Brazilian women. Eur J Obstet Gynecol Reprod Biol 134:20–23. doi:10.1016/j.ejogrb.2006.09.006 CrossRefPubMed

15.

de Paula Sabino A, Ribeiro DD, Carvalho M, das G et al (2006) Factor V Leiden and increased risk for arterial thrombotic disease in young Brazilian patients. Blood Coagul Fibrinolysis 17:271–275. doi:10.1097/01.mbc.0000224846.35001.64 CrossRefPubMed

Title: Is there a link among thrombophilia factors and preeclampsia?
Authors: Danyelle R. A. Rios
Patrícia Nessrala Alpoim
Lara Carvalho Godoi
Fernanda Santos Mendes
Bashir Lwaleed
Lirlândia P. Sousa
Luiza O. Perucci
Maria G. Carvalho
Karina B. G. Borges
Luci M. S. Dusse
Publication date: 01-11-2017
Publisher: Springer US
Published in: Journal of Thrombosis and Thrombolysis / Issue 4/2017
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI: https://doi.org/10.1007/s11239-017-1556-3

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Is there a link among thrombophilia factors and preeclampsia?

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2017

Prevalence of common hereditary risk factors for thrombophilia in Somalia and identification of a novel Gln544Arg mutation in coagulation factor V

Patients treated for acute VTE during periods of treatment-related thrombocytopenia have high rates of recurrent thrombosis and transfusion-related adverse outcomes

A systematic review of cost-effectiveness analysis of screening interventions for assessing the risk of venous thromboembolism in women considering combined oral contraceptives

Comparison of 4 different strategies of DAPT after PCI in ACS real world population from a Northern Italy registry

Outcome of intra-arterial thrombolysis in patients with diabetes and acute lower limb ischemia: a propensity score adjusted analysis

Highlights from the Ninth International Symposium of Thrombosis and Anticoagulation (ISTA IX), October 15, 2016, Salvador, Bahia, Brazil

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page